We are live on ! Find out more
GH

Geisinger Health Portfolio holdings

AUM $344M
1-Year Est. Return 4.22%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+4.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$312M
AUM Growth
-$99.4M
Cap. Flow
-$101M
Cap. Flow %
-32.33%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
4
Closed

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$25.3M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
1
iShares Core US Aggregate Bond ETF
AGG
$138B
$169M 54.1%
1,725,551
-241,710
-12% -$23.9M
HYG icon
2
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$81M 25.94%
1,079,543
+339,543
+46% +$25.3M
IWB icon
3
iShares Russell 1000 ETF
IWB
$47.6B
$37.7M 12.07%
154,665
-223,879
-59% -$51.6M
EFV icon
4
iShares MSCI EAFE Value ETF
EFV
$28.2B
$17.3M 5.55%
354,336
-190,664
-35% -$9.39M
IEFA icon
5
iShares Core MSCI EAFE ETF
IEFA
$187B
$7.34M 2.35%
108,797
-612,342
-85% -$41.5M

Similar funds

Geisinger Health's Q2 2023 Portfolio in Review

As of Q2 2023, Geisinger Health held 5 positions worth $312M, down 24% from $412M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Geisinger Health withdrew a net $101M in Q2 2023, reducing 4 holdings. Its largest reduction was iShares Russell 1000 ETF, cutting an estimated $51.6M.

Against the trend, Geisinger Health added an estimated $25.3M to iShares iBoxx $ High Yield Corporate Bond ETF.

  • Geisinger Health added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, an estimated $25.3M increase.
  • Geisinger Health's biggest Q2 2023 reduction was iShares Russell 1000 ETF, cutting an estimated $51.6M.
  • Geisinger Health's ten largest holdings make up 100% of its $312M portfolio in Q2 2023.
  • Geisinger Health opened 0 new positions and closed 0 in Q2 2023.
  • Geisinger Health's portfolio value fell 24% quarter-over-quarter to $312M.

Based on Geisinger Health's 13F filing for Q2 2023, filed 11 Aug 2023.